Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Depreciation & Amortization (CF) (2016 - 2026)

Healthequity has reported Depreciation & Amortization (CF) over the past 14 years, most recently at $38.7 million for Q1 2026.

  • Quarterly results put Depreciation & Amortization (CF) at $38.7 million for Q1 2026, down 1.28% from a year ago — trailing twelve months through Jan 2026 was $154.7 million (down 4.8% YoY), and the annual figure for FY2026 was $154.7 million, down 4.8%.
  • Depreciation & Amortization (CF) for Q1 2026 was $38.7 million at Healthequity, roughly flat from $38.8 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for HQY hit a ceiling of $43.6 million in Q3 2024 and a floor of $37.8 million in Q4 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $38.9 million (2024), compared with a mean of $39.4 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): increased 27.63% in 2022 and later decreased 11.82% in 2025.
  • Healthequity's Depreciation & Amortization (CF) stood at $40.5 million in 2022, then dropped by 6.72% to $37.8 million in 2023, then rose by 7.78% to $40.7 million in 2024, then fell by 4.77% to $38.8 million in 2025, then dropped by 0.25% to $38.7 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $38.7 million (Q1 2026), $38.8 million (Q4 2025), and $38.5 million (Q3 2025) per Business Quant data.